Drug Shortage Report for BIPAZEN
| Report ID | 232584 |
| Drug Identification Number | 02513579 |
| Brand name | BIPAZEN |
| Common or Proper name | Desmopressin Acetate Injection |
| Company Name | KVR PHARMACEUTICALS INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | DESMOPRESSIN ACETATE |
| Strength(s) | 4MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | Cartons of 10 ampoules |
| ATC code | H01BA |
| ATC description | POSTERIOR PITUITARY LOBE HORMONES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-07-19 |
| Actual start date | |
| Estimated end date | 2024-11-04 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-10-08 |
| Company comments | Discovered a quality issue with the lot of glass ampoules to be used in the next production. A new lot of glass ampoules have been ordered for rush delivery. Upon arrival, a new Bipazen batch will be produced. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 21 PARR BLVD, UNIT 12 CALEDON, ONTARIO CANADA L7E 4G3 |
| Company contact information | 1 877 302 2561 ext 101 info@kvrpharma.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v15 | 2024-10-08 | French | Compare |
| v14 | 2024-10-08 | English | Compare |
| v13 | 2024-09-16 | French | Compare |
| v12 | 2024-09-16 | English | Compare |
| v11 | 2024-07-20 | English | Compare |
| v10 | 2024-07-15 | French | Compare |
| v9 | 2024-07-15 | English | Compare |
| v8 | 2024-07-09 | French | Compare |
| v7 | 2024-07-09 | English | Compare |
| v6 | 2024-07-09 | French | Compare |
| v5 | 2024-07-09 | English | Compare |
| v4 | 2024-07-09 | French | Compare |
| v3 | 2024-07-09 | English | Compare |
| v2 | 2024-07-09 | English | Compare |
| v1 | 2024-07-09 | English | Compare |
Showing 1 to 15 of 15